This LP-IR Test Scores Insulin Resistance From 0 to 100 and Here’s What That Number Actually Means

Insulin resistance often develops silently, well before blood sugar climbs into prediabetic range, which is why the right lab work can flag trouble years before a diabetes diagnosis. Here’s what to know about the panels, scores and screening tools doctors use to detect insulin resistance and guide next steps.

What Lab Tests Can Detect Insulin Resistance Early?

There is no single gold-standard test for insulin resistance used in everyday practice. Doctors typically combine fasting glucose, hemoglobin A1C, fasting insulin and a lipid profile, then add more specific tools like HOMA-IR or a Lipoprotein Insulin Resistance score when the picture warrants a closer look. The South Carolina Department of Public Health says the oral glucose tolerance test (OGTT) is used less often because it is more expensive and harder to administer.

Each screening tool measures something slightly different. “The A1C test reflects your average blood glucose over the past 3 months. The FPG and OGTT show your blood glucose level at the time of the test,” the department explains. “The A1C test is not as sensitive as the other tests. In some people, it may miss prediabetes that the OGTT could catch. The OGTT can identify how your body handles glucose after a meal — often before your fasting blood glucose level becomes abnormal.”

According to Medscape’s workup overview, diagnosis relies on a combination of clinical findings and laboratory markers. Recommended testing includes fasting glucose, hemoglobin A1C, fasting insulin and a lipid profile, with particular attention to elevated triglycerides and low HDL cholesterol. Additional markers that help assess metabolic and cardiovascular risk include uric acid, microalbuminuria and C-reactive protein. Medscape notes the euglycemic insulin clamp remains the research gold standard but is not used in routine clinical practice.

What Is the LP-IR Test and What Does the Score Mean?

“The Lipoprotein Insulin Resistance (LP-IR) Test provides an advanced look at your metabolic health by estimating your body’s response to insulin, a hormone that helps control blood sugar. It looks at patterns in blood fats (lipoproteins) and gives you a score from 0 to 100. A lower score suggests better insulin response, while a higher score suggests more insulin resistance,” per Labcorp. The company says the score “may help identify risk for type 2 diabetes early, even before blood sugar changes.”

Dr. Margery Connelly told Labcorp that “the LP-IR measures changes in six lipoprotein markers that indicate when a person has insulin resistance.” She added that “scores of 68 or above indicate a higher risk of progressing to type 2 diabetes.”

The appeal of the LP-IR is its early-warning potential. Standard glucose tests show trouble only after blood sugar starts to rise, but lipoprotein changes can precede that shift. “Anyone who wants to learn more about progressing to type 2 diabetes or their risk of heart disease should consider an insulin resistance test,” Connelly said.

Other lab panels take a different angle. The Suspected Insulin Resistance panel from Ulta Lab Tests bundles glucose, hemoglobin A1C and insulin into one diagnostic assessment used to evaluate insulin resistance, a condition the company describes as one in which “the body’s cells do not respond effectively to insulin, leading to elevated blood glucose levels.” Quest Diagnostics markets its Cardio IQ Insulin Resistance Panel as providing “an enhanced assessment of IR through the combined measurement of insulin and C-peptide from a single fasting blood specimen.”

How Does HOMA-IR Testing Work for Insulin Resistance?

HOMA-IR, short for Homeostatic Model Assessment of Insulin Resistance, is a calculation that estimates insulin resistance using two simple fasting lab values: fasting blood glucose and fasting insulin. Higher HOMA-IR numbers point to greater insulin resistance, meaning the body needs more insulin to keep glucose levels normal.

HOMA-IR is a mathematical model rather than a stand-alone blood draw. Because it depends only on routine fasting measurements, it is widely used in clinical practice and research to assess metabolic health, identify early signs of insulin resistance and track changes over time. It is commonly applied to patients at risk for prediabetes, type 2 diabetes, metabolic syndrome and cardiovascular disease.

There are limits to relying on fasting numbers alone, though. “Fasting insulin changes throughout the day, as well as during and after meals,” Connelly said. “Fasting insulin and glucose alone are not always good indicators of insulin resistance, especially in individual patients, because they can vary a lot between people as well as within each person.”

That variability is one reason Medscape’s workup recommends pairing HOMA-IR with other markers. The site lists fasting insulin levels, HOMA-IR and QUICKI as the most accessible direct measures of insulin resistance, while reserving the euglycemic insulin clamp for research settings. In day-to-day care, HOMA-IR is most useful when read alongside A1C, a lipid profile and the patient’s broader clinical picture — not as a single number that confirms or rules out the condition.

What Is the TG/HDL Ratio and How Does It Screen for Insulin Resistance?

The triglyceride-to-HDL cholesterol (TG/HDL-C) ratio is a simple, widely available screening marker that flags people who may have insulin resistance. A higher ratio is linked to an increased risk of prediabetes, type 2 diabetes, metabolic syndrome and cardiovascular disease.

Insulin resistance is often accompanied by a telltale lipid pattern: elevated triglycerides and reduced HDL cholesterol. That makes the TG/HDL ratio a useful surrogate measure of underlying metabolic dysfunction, even though it does not directly measure how cells respond to insulin. Patients can often find both numbers on a standard lipid panel already in their medical record, with no specialized order needed.

The ratio’s limits matter, too. It cannot definitively diagnose insulin resistance on its own. Clinicians use it as a practical screening tool to identify individuals who may benefit from further evaluation with more specific tests, such as fasting insulin, HOMA-IR or one of the dedicated insulin resistance panels offered by major labs.

When Should You Get Tested for Insulin Resistance and How Often?

“Anyone who wants to learn more about progressing to type 2 diabetes or their risk of heart disease should consider an insulin resistance test,” Connelly told Labcorp. She added that “insulin resistance scores should be rechecked at least 12 weeks after starting a lifestyle change,” giving the body enough time to show measurable shifts in the markers being tracked.

Cleveland Clinic emphasizes ongoing follow-up for anyone already diagnosed. “If you’ve been diagnosed with the condition, it’s important to see your healthcare provider regularly. They’ll check to make sure your blood sugar levels are in a healthy range and that your treatment is working,” the clinic advises. “If you’re experiencing symptoms of high blood sugar or prediabetes, contact your healthcare provider. They can run simple tests to check your blood sugar levels. If you have a family history of diabetes or insulin resistance, talk to your healthcare provider about your risk of developing it.”

This article was created by content specialists using various tools, including AI.